SOLTIyoung
@soltiyoung
SOLTI Young-New Generation Breast🧬 Impulsamos el crecimiento académico, científico y personal de jóvenes oncólogos
ID: 1781279083311042560
19-04-2024 11:10:21
28 Tweet
85 Followers
137 Following
Hey #ESMOBreast2024 attendees! Drop by the SOLTI #cancerresearch booth to check out our new AI cyclib tool, led by the amazing Meritxell Bellet. It’s not just for catching potential DDIs—it’ll also offer you alternatives. Don’t miss it!
SOLTI is stealing the show at #ESMOBREAST24 :) Cristina Saura Mafalda Oliveira Guillermo Villacampa #beSOLTI Vall d’Hebron Institute of Oncology (VHIO)
Another @SOLTIYoung rockstar killing it at #ESMOBreast2024! 💥 Rodrigo Sánchez-Bayona
Adopted from Chile, yet another proud @SOLTIYoung member Benjamin Walbaum, MD crushing it at the #ESMOYOC clinical case discussion at #ESMOBreast2024, expertly discussed by the always outstanding Sara Tolaney!
🗣️If you don't bet for medical education you won't have the next generation of medical oncologists to change science in the future Today Dr. Mafalda Oliveira talked about SOLTIyoung in the Young Oncologists Vesalius talk in #ESMOBREAST24. Spread the word! Rodrigo Sánchez-Bayona #beSOLTI
Here comes SOLTI #cancerresearch , here comes #precisionmedicine. Great Eva M Ciruelos presenting PATRICIA cohort C results. Interesting results (that now need confirmation): Luminal A/B HR+/HER2+ MBC might be good candidates to CT-free anti-HER2 regimes 👇🏻 #ASCO24 OncoAlert @prat_aleix
Proud to present part of my PhD research. CDK-SCORE, a new PAM50-based tool to stratify patients with HR+/HER2- aBC prior to CDK4/6i in the 1st line setting. Thanks Eva M Ciruelos SOLTI #cancerresearch SOLTIyoung
📣 Abierta la convocatoria 2024 de Becas Gilead Sciences a la Investigación Biomédica! 👇🏻 urlisolation.com/browser?clickI…
Sigue todas las novedades del próximo congreso #ESMO24 con nuestro Rodrigo Sánchez-Bayona #ESMOambassador 👇🏻
No olvides aplicar a la beca SOLTIyoung para asistir a #SABCS2024. Inscripción, traslado y manutención incluidos. Una oportunidad única para seguir creciendo y conectar con jóvenes oncólogos internacionales. 👉 Consulta las bases: gruposolti.org/soltiyoung/ #beSOLTI
¡Nuestra más sincera enhorabuena a las doctoras Ariadna Roqué Lloveras y Isabel Garcia Fructuoso por ser las primeras premiadas con la I Beca SOLTIyoung de formación en congresos internacionales 🔥! Nos vemos en #SABCS24 🚀! #beSOLTI
35yo with ILC G2 cT2(23)cN0cM0, gBRCA2+, HR+ BC with high genomic risk. After neoadjuvant chemo containing anthracyclines&taxanes with good response (ypT1c, 10% residual cellularity), what adjuvant treatment would you favor? Weekly poll with Dr. Elia Seguí, MD👩⚕️Results on friday!
📣No te pierdas los próximos 7-8 de noviembre el taller SOLTI #cancerresearch para Diseño de un Ensayo Clínico en Oncología para Jóvenes Investigadores 2024! Más detalles sobre programa e inscripción aquí 👇🏻 gruposolti.org/events/tallere…
2nd POLL OF THE WEEK w/Dr.Elia Seguí, MD!📊 41-year-old premenopausal female post-lumpectomy and SLNB for invasive ductal carcinoma (IDC), grade 1. Pathology: pT1b (8 mm), pN1 (1/2 nodes psitive). Oncotype DX Recurrence Score (RS): 14. Which adjuvant treatment would you favor?
Excited to share my doctoral thesis on luminal metastatic breast cancer treated with CDK4/6i, now published in European Journal of Cancer. Thanks to Eva M Ciruelos & Aleix Prat #PrecisionOncology for their invaluable support as well as SOLTI #cancerresearch #BreastCancer ejcancer.com/article/S0959-…
Congratulations to Adrienne Waks, MD, (Ada Waks), Associate Director of Clinical Research Dana-Farber’s Breast Oncology Center, on this prestigious George P. Canellos Award for Excellence in Clinical Investigation! Dana-Farber News Harvard Medical School
